SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001213900-21-035033
Filing Date
2021-06-30
Accepted
2021-06-30 15:56:04
Documents
19

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 TO FORM S-1 ea143554-s1a3_unicycivethera.htm S-1/A 1662213
2 OPINION OF SHEPPARD, MULLIN, RICHTER & HAMPTON LLP ea143554ex5-1_unicycive.htm EX-5.1 16843
3 CONSENT OF MAYER HOFFMAN MCCANN P.C., INDEPENDENT REGISTERED PUBLIC ACCOUNTING F ea143554ex23-1_unicycive.htm EX-23.1 2615
4 GRAPHIC image_001.jpg GRAPHIC 11465
5 GRAPHIC image_002.jpg GRAPHIC 45192
6 GRAPHIC image_003.jpg GRAPHIC 111047
7 GRAPHIC image_004.jpg GRAPHIC 64679
8 GRAPHIC image_005.jpg GRAPHIC 146890
9 GRAPHIC image_006.jpg GRAPHIC 31421
10 GRAPHIC image_007.jpg GRAPHIC 25838
11 GRAPHIC image_009.jpg GRAPHIC 49390
12 GRAPHIC image_010.jpg GRAPHIC 66947
13 GRAPHIC image_011.jpg GRAPHIC 68014
14 GRAPHIC image_012.jpg GRAPHIC 51166
15 GRAPHIC image_013.jpg GRAPHIC 52744
16 GRAPHIC image_014.jpg GRAPHIC 145070
17 GRAPHIC image_015.jpg GRAPHIC 27670
18 GRAPHIC image_016.jpg GRAPHIC 74548
19 GRAPHIC ex5-1_001.jpg GRAPHIC 8916
  Complete submission text file 0001213900-21-035033.txt   3035973
Mailing Address 5150 EL CAMINO REAL, SUITE A-32 LOS ALTOS CA 94022
Business Address 5150 EL CAMINO REAL, SUITE A-32 LOS ALTOS CA 94022 650-384-0642
Unicycive Therapeutics, Inc. (Filer) CIK: 0001766140 (see all company filings)

IRS No.: 813638692 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-256367 | Film No.: 211061881
SIC: 2834 Pharmaceutical Preparations